Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_3
2
25%
Ph not_applicable
1
13%
Ph phase_4
5
63%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
5(62.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (25.0%)
Phase 45 (62.5%)
N/A1 (12.5%)

Trials by Status

completed563%
withdrawn225%
active_not_recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingphase_4

Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

NCT07196631
completednot_applicable

Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures

NCT02875288
completedphase_4

Surgeon Infiltration QL Block Comparison

NCT03496610
completedphase_4

A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine

NCT04114058
completedphase_4

Pain Management in Response to Exparel vs. Standard Bupivicaine

NCT02499159
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07196631Phase 4

Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

Active Not Recruiting
NCT02875288Not Applicable

Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures

Completed
NCT03496610Phase 4

Surgeon Infiltration QL Block Comparison

Completed
NCT04114058Phase 4

A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine

Completed
NCT02499159Phase 4

Pain Management in Response to Exparel vs. Standard Bupivicaine

Completed
NCT03822182Phase 4

Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery

Completed
NCT02933814Phase 3

Liposomal Bupivacaine in Ambulatory Hand Surgery

Withdrawn
NCT03043027Phase 3

Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8